You have 9 free searches left this month | for more free features.

Condition

Non Small Cell Lung Cancer (1)

Non-small Cell Lung Cancer (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Heat Biologics (2)

Collaborator

Intervention

viagenpumatucel-l (2)

metronomic cyclophosphamide (1)

nivolumab (1)

pembrolizumab (1)

pemetrexed (1)

physician's choice regimen (vinorelbine, erlotinib, gemcitabine, paclitaxel, docetaxel, pemetrexed) (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

viagenpumatucel-l

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in United States (Viagenpumatucel-L, Nivolumab, Pembrolizumab)

Active, not recruiting

Non-small Cell Lung Cancer

Viagenpumatucel-L
+3 more

Tucson, Arizona
+15 more

Sep 22, 2021

Non Small Cell Lung Cancer Trial in United States (Viagenpumatucel-L, Metronomic Cyclophosphamide, Physician's Choice Regimen

Terminated

Has Results

Non Small Cell Lung Cancer

Viagenpumatucel-L
+2 more

Rogers, Arkansas
+15 more

Jan 24, 2020